106 related articles for article (PubMed ID: 12587939)
1. Quality of life after use of the patient activated atrial defibrillator.
Spurrell P; Mitchell A; Kamalvand K; Sulke N
Int J Clin Pract; 2003; 57(1):30-4. PubMed ID: 12587939
[TBL] [Abstract][Full Text] [Related]
2. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
[TBL] [Abstract][Full Text] [Related]
3. [Atrial defibrillator].
Jung W; Lüderitz B
Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804
[TBL] [Abstract][Full Text] [Related]
4. Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life.
Newman DM; Dorian P; Paquette M; Sulke N; Gold MR; Schwartzman DS; Schaaf K; Wood K; Johnson L;
Am Heart J; 2003 May; 145(5):841-6. PubMed ID: 12766741
[TBL] [Abstract][Full Text] [Related]
5. Improving the acceptability of the atrial defibrillator for the treatment of persistent atrial fibrillation: the atrial defibrillator sedation assessment study (ADSAS).
Mitchell AR; Spurrell PA; Gerritse BE; Sulke N
Int J Cardiol; 2004 Aug; 96(2):141-5. PubMed ID: 15262026
[TBL] [Abstract][Full Text] [Related]
6. Reduction of ventricular tachyarrhythmia by treatment of atrial fibrillation in ICD patients with dual-chamber implantable cardioverter/defibrillators capable of atrial therapy delivery: the REVERT-AF Study.
Gradaus R; Seidl K; Korte T; Himmrich E; Wieneke H; Schuchert A; Bauer W; Gerss J; Wollmann CG; Borggrefe M; Böcker D
Europace; 2007 Jul; 9(7):534-9. PubMed ID: 17440005
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial aspects of patient-activated atrial defibrillation.
Mitchell AR; Spurrell PA; Boodhoo L; Sulke N
J Cardiovasc Electrophysiol; 2003 Aug; 14(8):812-6. PubMed ID: 12890040
[TBL] [Abstract][Full Text] [Related]
8. [Atrial defibrillators or implantable atrioverters. Initial results].
Lévy S; Taramasco V; Corbelli JL; Mistretta R; Dolla E; Ricard P
Arch Mal Coeur Vaiss; 1998 Jul; 91(7):887-91. PubMed ID: 9749182
[TBL] [Abstract][Full Text] [Related]
9. Myocardial injury, neurohormonal activation and inflammation after internal atrial defibrillation.
Boodhoo LE; Mitchell AR; O'Connor J; Sulke N
Int J Cardiol; 2005 Aug; 103(1):67-72. PubMed ID: 16061126
[TBL] [Abstract][Full Text] [Related]
10. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
[TBL] [Abstract][Full Text] [Related]
11. Understanding atrial symptom reports: objective versus subjective predictors.
Sears SF; Serber ER; Alvarez LG; Schwartzman DS; Hoyt RH; Ujhelyi MR
Pacing Clin Electrophysiol; 2005 Aug; 28(8):801-7. PubMed ID: 16105008
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST).
Fleischmann KE; Orav EJ; Lamas GA; Mangione CM; Schron EB; Lee KL; Goldman L;
Am Heart J; 2009 Jul; 158(1):78-83.e2. PubMed ID: 19540395
[TBL] [Abstract][Full Text] [Related]
13. Circadian variation of arrhythmia onset patterns in patients with persistent atrial fibrillation.
Mitchell AR; Spurrell PA; Sulke N
Am Heart J; 2003 Nov; 146(5):902-7. PubMed ID: 14597942
[TBL] [Abstract][Full Text] [Related]
14. Long-term health-related quality of life after maze surgery for atrial fibrillation.
Lundberg C; Albåge A; Carnlöf C; Kennebäck G
Ann Thorac Surg; 2008 Dec; 86(6):1878-82. PubMed ID: 19022001
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Jenkins LS; Brodsky M; Schron E; Chung M; Rocco T; Lader E; Constantine M; Sheppard R; Holmes D; Mateski D; Floden L; Prasun M; Greene HL; Shemanski L
Am Heart J; 2005 Jan; 149(1):112-20. PubMed ID: 15660042
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic and asymptomatic atrial fibrillation after pulmonary vein ablation and the impact on quality of life.
Pontoppidan J; Nielsen JC; Poulsen SH; Hansen PS
Pacing Clin Electrophysiol; 2009 Jun; 32(6):717-26. PubMed ID: 19545333
[TBL] [Abstract][Full Text] [Related]
17. Intra-atrial defibrillation in humans.
Lüderitz B; Jung W
Thorac Cardiovasc Surg; 1999 Aug; 47 Suppl 3():342-6. PubMed ID: 10520765
[TBL] [Abstract][Full Text] [Related]
18. Implantable atrial defibrillator for atrial fibrillation.
Sra J; Jazayeri MR; Dhala A; Blanck Z; Deshpande S; Akhtar M
WMJ; 1998 Nov; 97(10):37-6. PubMed ID: 9855792
[TBL] [Abstract][Full Text] [Related]
19. Lower body mass index and atrial fibrillation as independent predictors for mortality in patients with implantable cardioverter defibrillator.
Schernthaner C; Pichler M; Strohmer B
Croat Med J; 2007 Feb; 48(1):59-67. PubMed ID: 17309140
[TBL] [Abstract][Full Text] [Related]
20. Importance of preimplantation procedures in candidates for an implantable atrial defibrillator.
Seidl K; Hauer B; Kirca M; Drögemüller A; Werling C; Schwacke H; Zahn R; Saggau W; Senges J
J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S127-31. PubMed ID: 9727687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
